share_log
Reuters ·  May 16 07:00
Ionis Pharmaceuticals Inc: Ion582 Demonstrated Consistent Improvements Across Multiple Functional Domains in Angelman Syndrome Patients
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment